Related Experiment Videos

Deleterious synergism of a cardiac glycoside and sodium diatrizoate

Insights

Cardiac glycoside Strophanthin-K and contrast medium sodium diatrizoate show synergistic toxicity in mice, increasing mortality. This suggests caution for patients on cardiac glycosides undergoing contrast procedures.

Area of Science:

  • Pharmacology
  • Toxicology
  • Cardiology

Background:

  • Cardiac glycosides like Strophanthin-K are used for heart conditions.
  • Sodium diatrizoate is a common contrast medium for medical imaging.
  • Potential interactions between these agents require investigation.

Purpose of the Study:

  • To investigate the synergistic toxicity of Strophanthin-K and sodium diatrizoate in a murine model.
  • To determine if combined administration increases mortality compared to individual agents.

Main Methods:

  • Mice were administered intravenous injections of Strophanthin-K and sodium diatrizoate.
  • Lethal and near-lethal doses of each agent were tested individually and in combination.
  • Control groups received saline solutions.

Main Results:

  • Combined Strophanthin-K and sodium diatrizoate injections resulted in significantly higher mortality rates than individual agents.
  • Even low doses of one agent combined with lethal doses of the other significantly increased mortality.
  • Saline controls did not exhibit synergistic toxicity, indicating the agents themselves are responsible.

Conclusions:

  • A synergistic toxic interaction exists between Strophanthin-K and sodium diatrizoate, leading to increased mortality in mice.
  • The diatrizoate anion appears to be a key factor in this synergistic effect.
  • Patients on cardiac glycosides may face elevated risks from contrast media during procedures like intravenous urography.

Related Concept Videos